IPP Bureau
Zydus receives tentative approval from the USFDA for Canagliflozin tablets
By IPP Bureau - February 16, 2023
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya
Aurobindo Pharma gets VAI classification from USFDA for Telangana plant
By IPP Bureau - February 16, 2023
Company's Unit - IX, an API intermediate facility situated at Sangareddy District, Telangana, has now been classified as Voluntary Action Indicated
Panacea Biotec posts Q3 FY2023 net profit at Rs.19.37 crores
By IPP Bureau - February 16, 2023
The company has reported total income of Rs.129.14 crores during the period ended December 31, 2022 as compared to Rs.157.54 crores during the period ended December 31, 2021.
Thermo Fisher Scientific launches real-time PCR kits for detection of infectious diseases in India
By IPP Bureau - February 15, 2023
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Wockhardt registers Q3 FY23 consolidated loss at Rs. 96 Cr
By IPP Bureau - February 15, 2023
The company has reported total income of Rs. 701 crores during the period ended December 31, 2022
ISHIC partners with the DGHS Jammu to bring down the burden of lung cancer in India
By IPP Bureau - February 15, 2023
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
Johnson & Johnson appoints Dr. John Reed as EVP, Pharmaceuticals, R&D
By IPP Bureau - February 15, 2023
Univar Solutions expands ingredients portfolio through new distribution agreement with SI Group
By IPP Bureau - February 15, 2023
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
NATCO files generic Olaparib Tablets in USA
By IPP Bureau - February 14, 2023
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
Infosys Foundation collaborates with Health Department of Karnataka
By IPP Bureau - February 14, 2023
Through this collaboration, the erstwhile Government Maternity Hospital in Kanakapura Taluk has been rebuilt and the new hospital has facilities including oxygen and medical gas pipelines
Thermo Fisher Scientific to introduce fully automated cell line automation platform
By IPP Bureau - February 14, 2023
Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics RoboCell cell line automation platform
FDA approves Pfizer's supplemental new drug application for CIBINQO
By IPP Bureau - February 14, 2023
Label expansion for CIBINQO provides new systemic oral option for adolescents (12 to <18 years) with moderate-to-severe atopic dermatitis
Sanofi announces change in R&D leadership
By IPP Bureau - February 14, 2023
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Govt. improving healthcare and medical education through holistic approach: Dr. Mandaviya
By IPP Bureau - February 13, 2023
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
India committed to strengthen traditional medicine practice by bolstering evidence-based research: Sonowal
By IPP Bureau - February 13, 2023
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
